Journal of Molecular and Cellular Cardiology
Volume 48, Issue 3 , Pages 474-482 , March 2010

The extracellular matrix: At the center of it all

Received 27 April 2009 ,Revised 9 August 2009 ,Accepted 21 August 2009.

References 

  1. Davis GE, Senger DR. Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Curr. Opin. Hematol. 2008;15:197–203
  2. Schor SL, Schor AM. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res. 2001;3:373–379
  3. Weber KT. From inflammation to fibrosis: a stiff stretch of highway. Hypertension. 2004;43:716–719
  4. Larue L, Bellacosa A. Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene. 2005;24:7443–7454
  5. Manasek FJ. Embryonic development of the heart. II. Formation of the epicardium. J. Embrol. Exp. Morphol. 1969;22:333–348
  6. Norris RA, Borg TK, Butcher JT, Baudino TA, Banerjee I, Markwald RR. Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Ann. N.Y. Acad. Sci. 2008;1123:30–40
  7. Huang JX, Potts JD, Vincent EB, Weeks DL, Runyan RB. Mechanisms of cell transformation in the embryonic heart. Ann. N.Y. Acad. Sci. 1995;752:317–330
  8. Runyan RB, Potts JD, Sharma RV, Loeber CP, Chiang JJ, Bhalla RC. Signal transduction of a tissue interaction during embryonic heart development. Cell Regul. 1990;1:301–313
  9. Sridurongrit S, Larsson J, Schwartz R, Ruiz-Lozano P, Kaartinen V. Signaling via the Tgf-β type I receptor Alk5 in heart development. Dev. Biol. 2008;322:208–218
  10. Delot EC. Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. Mol. Genet. Metab. 2003;80:27–35
  11. Bernanke DH, Markwald RR. Effects of two glycosaminoglycans on seeding of cardiac cushion tissue cells into a collagen-lattice culture system. Anat. Rec. 1984;210:25–31
  12. Butcher JT, Markwald RR. Valvulogenesis: the moving target. Philos. Trans. R. Soc. B. 2007;362:1489–1503
  13. Butcher JT, Norris RA, Hoffman S, Mjaatvedt CH, Markwald RR. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev. Biol. 2007;302:256–266
  14. Schroeder JA, Jackson LF, Lee DC, Camenisch TD. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J. Mol. Med. 2003;81:392–403
  15. Kruithof BPT, Krawitz SA, Gaussin V. Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev. Biol. 2007;302:208–217
  16. Beppu H, Malhotra R, Beppu Y, Lepore JJ, Parmacek MS, Bloch KD. BMP type II receptor regulates positioning of outflow tract and remodeling of atrioventricular cushion during cardiogenesis. Dev. Biol. 2009;331:167–175
  17. Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 2005;65:40–51
  18. Borg TK, Caulfield JB. Morphology of connective tissue in skeletal muscle. Tissue Cell. 1980;12:197–207
  19. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ. Res. 2002;91:1103–1113
  20. Corda S, Samuel JL, Rappaport L. Extracellular matrix and growth factors during heart growth. Heart Fail. Rev. 2000;5:119–130
  21. Jane-Lise S, Corda S, Chassagne C, Rappaport L. The extracellular matrix and the cytoskeleton in heart hypertrophy and failure. Heart Fail. Rev. 2000;5:239–250
  22. Baudino TA, Carver W, Giles W, Borg TK. Cardiac fibroblasts: friend or foe?. Am. J. Physiol., Heart Circ. Physiol. 2006;291:H1015–H1026
  23. Katsuragi N, Morishita R, Nakamura N, Ochiai T, Taniyama Y, Hasegawa Y, et al. Periostin as a novel factor responsible for ventricular dilation. Circulation. 2004;110:1806–1813
  24. MacKenna D, Summerour SR, Villarreal FJ. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc. Res. 2000;46:257–263
  25. Matsushita T, Oyamada M, Fujimoto K, Yasuda Y, Masuda S, Wada Y, et al. Remodeling of cell–cell and cell-extracellular matrix interactions at the border zone of rat myocardial infarcts. Circ. Res. 1999;85:1046–1055
  26. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol. Rev. 2007;87:1285–1342
  27. Ross RS, Borg TK. Integrins and the myocardium. Circ. Res. 2001;88:1112–1119
  28. Graham HK, Horn M, Trafford AW. Extracellular matrix profiles in the progression to heart failure. European Young Physiologists Symposium Keynote Lecture-Bratislava 2007. Acta Physiol. (Oxf). 2008;194:3–21
  29. Sussman MA, McCulloch A, Borg TK. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ. Res. 2002;91:888–898
  30. Burgess ML, Buggy J, Price RL, Abel FL, Terracio L, Samarel AM, et al. Exercise- and hypertension-induced collagen changes are related to left ventricular function in rat hearts. Am. J. Physiol. 1996;270:H151–H159
  31. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am. J. Physiol., Heart Circ. Physiol. 2007;293:H1883–H1891
  32. Mueller XM, Tevaearai HT, Tucker O, Boone Y, von Segesser L. Reshaping the remodelled left ventricle: a new concept. Eur. J. Cardio-thorac. Surg. 2001;20:786–791
  33. Edwards CA, O’Brien WD. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin. Chim. Acta. 1980;104:161–167
  34. Li F, Wang X, Capasso JM, Gerdes AM. Transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 1996;28:1737–1746
  35. Dobacewski M, Bujak M, Zymek P, Ren G, Entman ML, Frangogiannis NG. Extracellular matrix remodeling in canine and mouse myocardial infarcts. Cell Tissue Res. 2006;324:475–488
  36. Villar AV, Llano M, Cobo M, Espósito V, Merino R, Martín-Durán R, et al. Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. J. Mol. Cell. Cardiol. 2009;46:526–535
  37. Liu H, Chen B, Lilly B. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1. Angiogenesis. 2008;11:223–234
  38. Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J. Cell. Sci. 2006;119:3901–3903
  39. Ieda M, Tsuchihashi T, Ivey KN, Ross RS, Hong TT, Shaw RM, et al. Cardiac fibroblasts regulate myocardial proliferation through β1 integrin signaling. Dev. Cell. 2009;16:233–244
  40. Sun M, Opavsky MA, Steward DJ, Rabinovitch M, Dawood F, Wen W, et al. Temporal response and localization of integrins β1 and β3 in the heart after myocardial infarction: regulation by cytokines. Circ. 2003;107:1046–1052
  41. Fielding AB, Dobreva I, Dedhar S. Beyond focal adhesions: integrin-linked kinase associates with tubulin and regulates mitotic spindle organization. Cell Cycle. 2008;7:1899–1906
  42. Astrof S, Hynes RO. Fibronectins in vascular morphogenesis. Angiogenesis. 2009;12:165–175
  43. Peacock JD, Lu Y, Koch M, Kadler KE, Lincoln J. Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance. Dev. Dyn. 2008;237:3038–3051
  44. Sarkar S, Vellaichamy E, Young D, Sen S. Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. Am. J. Physiol., Heart Circ. Physiol. 2004;287:H107–H117
  45. Liu J, He X, Corbett SA, Lowry SF, Graham AM, Fassler R, et al. Integrins are required for the differentiation of visceral endoderm. J. Cell. Sci. 2008;122:233–242
  46. Kohl P, Camelliti P, Burton FL, Smith GL. Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J. Electrocardiol. 2005;38:45–50
  47. Sachse FB, Moreno AP, Abildskov JA. Electrophysiological modeling of fibroblasts and their interaction with myocytes. Ann. Biomed. Eng. 2008;36:41–56
  48. Mjaatvedt CH, Kern CB, Norris RA, Fairey S, Cave CL. Normal distribution of melanocytes in the mouse heart. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 2005;285:748–757
  49. Litvin J, Zhu S, Norris R, Markwald R. Periostin family of proteins: therapeutic targets for heart disease. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 2005;287:1205–1212
  50. Lindsley A, Li W, Wang J, Maeda N, Rogers R, Conway SJ. Comparison of the four mouse fasciclin-containing genes expression patterns during valvuloseptal morphogenesis. Gene Expr. Patterns. 2005;5:593–600
  51. Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, et al. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ. Res. 2008;102:752–760
  52. Lindner V, Wang Q, Conley BA, Friesel RE, Vary CPH. Vascular injury induces expression of periostin implications for vascular cell differentiation and migration. Arterioscler. Thromb. Vasc. Biol. 2005;25:77–83
  53. Banerjee I, Fuseler JW, Intwala AR, Baudino TA. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density and dramatically alters the cell populations of the developing and adult heart. Am. J. Physiol., Heart Circ. Physiol. 2009;296:H1694–H1704
  54. Kühn B, delMonte F, Hajjar RJ, Chang YS, Lebeche D, Arab S, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat. Med. 2007;13:962–969
  55. Li P, Oparil S, Feng W, Chen YF. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct pathways in rat pulmonary arterial smooth muscle cells. J. Appl. Physiol. 2004;97:1550–1558
  56. Lorts A, Schwanekamp JA, Elrod JW, Sargent MA, Molkentin JD. Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell activity or cardiac repair. Circ Res. 2009;104:e1–7
  57. Li YY, McTiernan CF, Feldman AM. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. 2000;46:214–224
  58. Lindsey ML, Goshorn DK, Squires CE, Escobar GP, Hendrick JW, Mingoia JT, et al. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc. Res. 2005;66:410–419
  59. Peterson JT, Li H, Dillon L, Bryant JW. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 2000;46:307–315
  60. Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, et al. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation. 2006;113:2919–2928
  61. Maquart FX, Bellon G, Pasco S, Monboisse JC. Matrikines in the regulation of extracellular matrix degradation. Biochimie. 2005;87:353–360
  62. Davis GE, Bayless KJ, Davis MJ, Meininger GA. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am. J. Pathol. 2000;156:1489–1498
  63. Robinet A, Millart H, Oszust F, Hornebeck W, Bellon G. Binding of elastin peptides to S-Gal protects the heart against ischemia/reperfusion injury by triggering the RISK pathway. FASEB J. 2007;21:1968–1978
  64. Mann DL. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu. Rev. Physiol. 2003;65:81–101
  65. Hirota H, Izumi M, Hamaguchi T, Sugiyama S, Murakami E, Kunisada K, et al. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels. 2004;19:237–241
  66. Mironov V, Visconti RP, Kasyanov V, Forgacs G, Drake CJ, Markwald RR. Organ printing: tissue spheroids as building blocks. Biomaterials. 2009;30:2164–2174
  67. Geisse NA, Sheehy SP, Parker KK. Control of myocyte remodeling in vitro with engineered substrates. In Vitro Cell. Dev. Biol., Anim. 2009;45:343–350

PII: S0022-2828(09)00360-5

doi: 10.1016/j.yjmcc.2009.08.024

Journal of Molecular and Cellular Cardiology
Volume 48, Issue 3 , Pages 474-482 , March 2010

Article Tools

* Image Usage & Resolution